Serendipity in anticancer drug discovery

doi:10.5306/wjco.v3.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13922)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

765

HTML

12686

Figures (1-2)

167

Tables (1-5)

304

Sum=13922

Jan 10, 2012 (publication date) through Jul 10, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observation

World J Clin Oncol. Jan 10, 2012; 3(1): 1-6
Published online Jan 10, 2012. doi: 10.5306/wjco.v3.i1.1

Open in New Tab Full Size Figure Download Figure

Figure 1 The distribution of the serendipity types (laboratory-based and clinical) and their chemical derivatives in clinical use (100% = 1437).

Open in New Tab Full Size Figure Download Figure

Figure 2 The statistical distribution of anticancer drugs discovered with the aid of serendipity and their chemical derivatives in clinical use (100% = 88).

Citation: Hargrave-Thomas E, Yu B, Reynisson J. Serendipity in anticancer drug discovery. World J Clin Oncol 2012; 3(1): 1-6
URL: https://www.wjgnet.com/2218-4333/full/v3/i1/1.htm
DOI: https://dx.doi.org/10.5306/wjco.v3.i1.1